The U.S. Food and Drug Administration approved Vertex Pharmaceutical Inc.’s cystic-fibrosis drug Orkambi, which could treat as many as 8,500 patients in the U. S. — but at a whopping […]
NEW YORK–(BUSINESS WIRE)–Enzo Biochem, Inc. (NYSE:ENZ) today announced that it has reached and finalized a settlement with Luminex Corporation (NASDAQ:LMNX) involving payment of $7.1 million to Enzo in an infringement […]
As the larger Aetna (AET) looks to the future following its proposed acquisition of Humana (HUM), one key area under consideration would be to bring the management of its large […]
DUBLIN, IRELAND–(Marketwired – Jul 6, 2015) – Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines […]
It’s not often that Nature publishes on a new way of detecting cancer. Recently the journal reported that bits of cancerous cells – tiny blebs containing protein, RNA and DNA […]
In less than one year ‒ we’ve seen a staggering number of data breaches in healthcare. Almost 96 million records were stolen in just 3 high‒profile cases alone ‒ Community […]
One U.S. biotech company is celebrating Independence Day weekend with a fresh $1 billion in cash from a corporate partner, which it was able to secure without giving up its […]
The big are getting bigger: Aetna and Humana, the nation’s number three and number four health insurers by revenue, are merging. Aetna will pay about $230 per share for Humana, […]
HARTFORD, Conn. & LOUISVILLE, Ky.–(BUSINESS WIRE)–Aetna (NYSE: AET) and Humana Inc. (NYSE: HUM) today announced that they have entered into a definitive agreement under which Aetna will acquire all outstanding […]
FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (NASDAQ:GILD) today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Harvoni® (ledipasvir 90 mg/sofosbuvir 400 mg), the first once-daily […]
